# D-SPARK: A Clinical Trial of D-Serine for Modifying Parkinson's Disease Progression

> **NCT07312110** · PHASE2 · RECRUITING · sponsor: **Haukeland University Hospital** · enrollment: 100 (estimated)

## Conditions studied

- Parkinson s Disease
- Parkinson Disease (PD)

## Interventions

- **DIETARY_SUPPLEMENT:** D-serine
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT07312110
- **Lead sponsor:** Haukeland University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-01
- **Primary completion:** 2028-03
- **Final completion:** 2028-12
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2026-01-06

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07312110

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07312110, "D-SPARK: A Clinical Trial of D-Serine for Modifying Parkinson's Disease Progression". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07312110. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*